Basic research and therapeutic strategies for multinodular hepatocellular carcinoma
10.3969/j.issn.1001-5256.2016.06.046
- VernacularTitle:多结节肝细胞癌的基础研究及治疗策略
- Author:
Zhenyu YANG
1
;
Xilin DU
;
Tao YANG
Author Information
1. Department of General Surgery, Tangdu Hospital of Fourth Military Medical University, Xi′an 710038, China)
- Publication Type:Research Article
- Keywords:
carcinoma, hepatocellular;
proteomics;
therapy;
review
- From:
Journal of Clinical Hepatology
2016;32(6):1212-1215
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, with the development of in-depth basic and clinical research on hepatocellular carcinoma (HCC), the heterogeneity, biological characteristics, molecular subtyping, and individualized treatment of HCC have gradually become the basic guiding principles for the clinical treatment of HCC in the modern era. Multinodular HCC is a form of gross specimens of HCC, and new achievements have been made in the molecular origin and guidelines for clinical typing of HCC, which guide the diagnosis and treatment of HCC. However, new controversies have also appeared. This article reviews the advances in basic and clinical research on multinodular HCC, hoping to provide a reference for clinical prevention and treatment of HCC and contribute to patients' survival benefit.
